Stemson Therapeutics is developing a novel cure for hair loss using iPS-derived cells to generate de novo hair follicles. The company integrates cell and tissue engineering technology with biomaterial engineering and robotic transplantation to deliver an unlimited supply of new hair follicles to patients in need.
